Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of tramadol hydrochloride sustained-release tablets (fasting and postprandial) in healthy Chinese volunteers
ChiCTR2300073437Phase 4Not yet recruiting
- Sponsor
- Guangzhou Panyu District Central Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tramadol in pain (4 arms), sponsored by Guangzhou Panyu District Central Hospital. Primary endpoints: Cmax, AUC0-∞ and 1 more. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
tramadol
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR2300073437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073437.